Evergreen Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Evergreen Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$854K	Hold	6,686	–	–	0.02%	542
2025 Q4	$815K	Hold	6,686	–	–	0.02%	529
2025 Q3	$670K	Hold	6,686	–	–	0.02%	527
2025 Q2	$554K	Buy	6,686 +1,625	+32%	+$130K	0.02%	519
2025 Q1	$410K	Hold	5,061	–	–	0.01%	586
2024 Q4	$456K	Hold	5,061	–	–	0.01%	544
2024 Q3	$500K	Hold	5,061	–	–	0.02%	496
2024 Q2	$469K	Hold	5,061	–	–	0.02%	485
2024 Q1	$480K	Buy	5,061 +61	+1%	+$5.66K	0.02%	460
2023 Q4	$446K	Hold	5,000	–	–	0.02%	450
2023 Q3	$365K	Hold	5,000	–	–	0.02%	489
2023 Q2	$416K	Hold	5,000	–	–	0.02%	439
2023 Q1	$381K	Sell	5,000 -50	-1%	-$4.15K	0.02%	439
2022 Q4	$419K	Hold	5,050	–	–	0.02%	404
2022 Q3	$401K	Hold	5,050	–	–	0.02%	387
2022 Q2	$375K	Sell	5,050 -11	-0.2%	-$826	0.02%	379
2022 Q1	$455K	Hold	5,061	–	–	0.02%	396
2021 Q4	$567K	Hold	5,061	–	–	0.02%	356
2021 Q3	$636K	Hold	5,061	–	–	0.03%	327
2021 Q2	$685K	Hold	5,061	–	–	0.03%	301
2021 Q1	$687K	Hold	5,061	–	–	0.04%	290
2020 Q4	$712K	Sell	5,061 -5,900	-54%	-$756K	0.04%	253
2020 Q3	$1.22M	Hold	10,961	–	–	0.08%	186
2020 Q2	$1.23M	Buy	10,961 +561	+5%	+$55.3K	0.09%	175
2020 Q1	$805K	Buy	10,400 +600	+6%	+$53.1K	0.08%	183
2019 Q4	$932K	Hold	9,800	–	–	0.08%	178
2019 Q3	$747K	Hold	9,800	–	–	0.07%	180
2019 Q2	$860K	Buy	9,800 +4,800	+96%	+$409K	0.08%	173
2019 Q1	$453K	Hold	5,000	–	–	0.05%	225
2018 Q4	$359K	Sell	5,000 -1,800	-26%	-$145K	0.04%	240
2018 Q3	$652K	Hold	6,800	–	–	0.06%	201
2018 Q2	$647K	Buy	+6,800	New	+$625K	0.06%	195

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Evergreen Capital Management's XBI Position: Q1 2026 in Review

Evergreen Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 6,686 shares worth $854K. The position accounts for 0.02% of the portfolio, ranked #542.

Evergreen Capital Management first reported a position in XBI in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.23M in Q2 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Evergreen Capital Management held 6,686 shares of State Street SPDR S&P Biotech ETF worth $854K as of Q1 2026.
Evergreen Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Evergreen Capital Management's portfolio in Q1 2026, its #542 holding.
Evergreen Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 32 quarters since.
Evergreen Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.23M in Q2 2020.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.